Rubidomycin in Acute Leukaemia in AdultsBr Med J 1968; 3 doi: https://doi.org/10.1136/bmj.3.5612.227 (Published 27 July 1968) Cite this as: Br Med J 1968;3:227
- J. S. Malpas,
- Ronald Bodley Scott
In a preliminary study rubidomycin was found capable of inducing remission in adults with acute leukaemia, the remission rate in acute myeloblastic leukaemia comparing favourably with that achieved with previous forms of therapy. Marrow aplasia and cardio-toxicity occurred in a number of patients. Supportive measures during the former and early recognition by frequent electrocardiography can do much to mitigate these toxic effects.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial